NCT02203019View on ClinicalTrials.gov

Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 22, 2016

Study Completion Date

September 22, 2016

Conditions
SepsisRespiratory FailureAgitation
Interventions
DRUG

Propofol

Propofol will be administered for sedation in mechanically ventilated patients with sepsis.

DRUG

Dexmedetomidine

Dexmedetomidine will be administered for sedation in mechanically ventilated patients with sepsis.

DRUG

Fentanyl

"Fentanyl will be administered for analgesia in mechanically ventilated patients with sepsis. The use of Fentanyl is not an intervention of interest."

Trial Locations (1)

79415

University Medical Center, Lubbock

All Listed Sponsors
lead

Texas Tech University Health Sciences Center

OTHER

NCT02203019 - Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure | Biotech Hunter | Biotech Hunter